Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurens J De Sadeleer

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Chest|September 10, 2018
ResponseLaurens J De Sadeleer, Wim A Wuyts
Journal of Clinical Medicine|June 7, 2020
Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next StageLaurens J De Sadeleer, Tinne Goos, Jonas Yserbyt, et al.
Respiratory Medicine|December 4, 2020
Statins: cause of fibrosis or the opposite? Effect of cardiovascular drugs in idiopathic pulmonary fibrosisEline M Lambert, Wim A Wuyts, Jonas Yserbyt, et al.
Current Opinion in Pulmonary Medicine|July 24, 2020
Advances in lung transplantation for interstitial lung diseasesLaurens J De Sadeleer, Stijn E Verleden, Robin Vos, et al.
Lung|March 14, 2018
Prevalence of Myositis-Specific Antibodies in Idiopathic Interstitial PneumoniasLaurens J De Sadeleer, Ellen De Langhe, Nicolas Bodart, et al.
Allergy, Asthma & Immunology Research|May 14, 2020
Skin Exposure Contributes to Chemical-Induced Asthma: What is the Evidence? A Systematic Review of Animal ModelsHung Chang Tsui, Steven Ronsmans, Laurens J De Sadeleer, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|August 20, 2021
Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a reviewSaskia Bos, Laurens J De Sadeleer, Arno Vanstapel, et al.
Journal of Clinical Medicine|April 3, 2021
Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to BeTinne Goos, Laurens J De Sadeleer, Jonas Yserbyt, et al.
Rheumatology Advances in Practice|May 4, 2026
The prevalence of interstitial lung disease in rheumatoid arthritis: a systematic reviewMarie Vermant, Thomas Pauwels, Tine Follet, et al.
Journal of Clinical Medicine|December 23, 2018
Effects of Corticosteroid Treatment and Antigen Avoidance in a Large Hypersensitivity Pneumonitis Cohort: A Single-Centre Cohort StudyLaurens J De Sadeleer, Frederik Hermans, Els De Dycker, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Chest|September 10, 2018
ResponseLaurens J De Sadeleer, Wim A Wuyts
Journal of Clinical Medicine|June 7, 2020
Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next StageLaurens J De Sadeleer, Tinne Goos, Jonas Yserbyt, et al.
Respiratory Medicine|December 4, 2020
Statins: cause of fibrosis or the opposite? Effect of cardiovascular drugs in idiopathic pulmonary fibrosisEline M Lambert, Wim A Wuyts, Jonas Yserbyt, et al.
Current Opinion in Pulmonary Medicine|July 24, 2020
Advances in lung transplantation for interstitial lung diseasesLaurens J De Sadeleer, Stijn E Verleden, Robin Vos, et al.
Lung|March 14, 2018
Prevalence of Myositis-Specific Antibodies in Idiopathic Interstitial PneumoniasLaurens J De Sadeleer, Ellen De Langhe, Nicolas Bodart, et al.
Allergy, Asthma & Immunology Research|May 14, 2020
Skin Exposure Contributes to Chemical-Induced Asthma: What is the Evidence? A Systematic Review of Animal ModelsHung Chang Tsui, Steven Ronsmans, Laurens J De Sadeleer, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|August 20, 2021
Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a reviewSaskia Bos, Laurens J De Sadeleer, Arno Vanstapel, et al.
Journal of Clinical Medicine|April 3, 2021
Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to BeTinne Goos, Laurens J De Sadeleer, Jonas Yserbyt, et al.
Rheumatology Advances in Practice|May 4, 2026
The prevalence of interstitial lung disease in rheumatoid arthritis: a systematic reviewMarie Vermant, Thomas Pauwels, Tine Follet, et al.
Journal of Clinical Medicine|December 23, 2018
Effects of Corticosteroid Treatment and Antigen Avoidance in a Large Hypersensitivity Pneumonitis Cohort: A Single-Centre Cohort StudyLaurens J De Sadeleer, Frederik Hermans, Els De Dycker, et al.
Pageof 4